ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2509

Cost-Effectiveness of Training Rural Providers to Perform Joint Injections

Michael J. Battistone1, Richard E. Nelson2, William D. Ashworth3, Andrea Barker3, Marissa Grotzke4, Timothy A. Huhtala5, Robert Z. Tashjian6 and Grant W. Cannon1, 1Division of Rheumatology, Salt Lake City VA and University of Utah, Salt Lake City, UT, 2Division of Epidemiology, Salt Lake City VA and University of Utah, Salt Lake City, UT, 3General Internal Medicine, Salt Lake City VA and University of Utah, Salt Lake City, UT, 4Division of Endocrinology, Salt Lake City VA and University of Utah, Salt Lake City, UT, 5Division of General Internal Medicine, Salt Lake City VA and University of Utah, Salt Lake City, UT, 6Division of Orthopaedics, Salt Lake City VA and University of Utah, Salt Lake City, UT

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Arthrocentesis, Decision analysis, Economics, Education, medical and osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: ACR/ARHP Combined Epidemiology Abstract Session

Session Type: Combined Abstract Sessions

Background/Purpose: Community based outpatient clinics (CBOCs) have been established by the Department of Veteran Affairs (VA) to provide primary care services to veterans living in remote and rural regions.  While CBOCs provide excellent primary care services, the current model does not allow providers in CBOCs to develop and deliver specialty services.   The objective of this study was to evaluate the cost-effectiveness of training rural primary care providers to perform knee injections in CBOCs, rather than referring the patient to an urban medical center with rheumatology and orthopaedic specialists. Referral often involves significant travel for patients in rural areas.

Methods: We developed a decision analytic model to compare costs and outcomes between rural providers who are trained to perform knee injections and those who are not trained. In the model, each type of provider is presented with a hypothetical patient who has knee pain and should receive an injection. Costs included in the model (including medical management for patients who do not receive an injection, training of the rural provider to perform injections, travel reimbursement for patients who are sent to an urban medical center) were from the perspective of the VHA. The effectiveness outcome was quality-adjusted life years (QALYs). In our primary analysis, a range of values were used for 2 key inputs: the number of patients with knee pain presenting to the rural clinic in 1 year period (range:10-100) and the average distance from the patients’ home address to the urban medical center (range:50-500). Probabilistic sensitivity analyses were performed using 1,000 2nd order Monte Carlo simulations and the benefits of knee injection were assumed to last 90 days.

Results: In our base case analyses (which assumed 30 patients per year presenting with knee pain that could benefit from an injection and an average distance of 100 miles from the patient’s home adders to the urban medical center), the incremental cost-effectiveness ratio (ICER) for trained rural providers was $27,692/QALY. ICERs were more sensitive to the number of patients than to distance Table 1. Training rural providers was cost-effective in 68.6% of 1,000 Monte Carlo simulations at a willingness to pay threshold of $50,000/QALY.

Incremental cost effectiveness ratios for range of values for average distance and number of patients per year   (US dollars/QALY)

 

Number of patients

Distance

10

30

50

100

50

$70,732

$27,888

$19,319

$12,893

100

$70,536

$27,692

$19,124

$12,697

200

$70,145

$27,301

$18,732

$12,305

500

$68,970

$26,126

$17,557

$11,130

Conclusion: Training rural providers to perform knee injections for patients with knee pain appears cost-effective at the commonly used threshold of $50,000/QALY if sufficient  numbers of such patients are seen at rural primary care clinics.  We are currently implementing such a training program  to test the validity of these projections.

 


Disclosure:

M. J. Battistone,
None;

R. E. Nelson,
None;

W. D. Ashworth,
None;

A. Barker,
None;

M. Grotzke,
None;

T. A. Huhtala,
None;

R. Z. Tashjian,
None;

G. W. Cannon,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cost-effectiveness-of-training-rural-providers-to-perform-joint-injections/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology